AbbVie Free Cash Flow Per Share from 2010 to 2024

ABBV Stock  USD 183.08  1.94  1.07%   
AbbVie Free Cash Flow Per Share yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Per Share is likely to outpace its year average in 2024. Free Cash Flow Per Share is the amount of cash AbbVie Inc generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. View All Fundamentals
 
Free Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
12.47850679
Current Value
13.1
Quarterly Volatility
4.18845129
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Free Cash Flow Per Share Growth Pattern

Below is the plot of the Free Cash Flow Per Share of AbbVie Inc over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. AbbVie's Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share10 Years Trend
Slightly volatile
   Free Cash Flow Per Share   
       Timeline  

AbbVie Free Cash Flow Per Share Regression Statistics

Arithmetic Mean7.27
Geometric Mean6.10
Coefficient Of Variation57.63
Mean Deviation3.71
Median5.91
Standard Deviation4.19
Sample Variance17.54
Range11.8503
R-Value0.93
Mean Square Error2.41
R-Squared0.87
Slope0.87
Total Sum of Squares245.60

AbbVie Free Cash Flow Per Share History

2024 13.1
2023 12.48
2022 13.69
2021 12.42
2020 10.07
2019 8.62
2018 8.3

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Per Share 12.48  13.10 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.